ZAI LAB Falls 8% to Over One-Year Low Following Disappointing 3Q Results
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 07 2025
0mins
Source: aastocks
Stock Performance: ZAI LAB's stock fell by 8.4% to HKD17.86, marking its lowest point since October 2024, with significant trading volume of 13.064 million shares.
Financial Results: For Q3 2025, ZAI LAB reported a 14% year-over-year revenue increase to USD116 million, but its losses narrowed to USD35.96 million from USD41.67 million the previous year.
Market Expectations: UBS noted that ZAI LAB's Q3 results were below expectations, with revenue 18% lower than anticipated and quarterly losses exceeding market forecasts.
Analyst Rating: Despite the disappointing results, UBS maintained a Buy rating on ZAI LAB, setting a target price of HKD33.5.
Analyst Views on 09688
Wall Street analysts forecast 09688 stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for 09688 is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 15.480
Low
Averages
High
Current: 15.480
Low
Averages
High
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
